(29 days)
Not Found
No
The document describes a hip implant and its intended use, focusing on material and design modifications compared to a predicate device. There is no mention of AI or ML in the intended use, device description, or performance studies.
Yes.
The device is indicated for conditions like osteoarthritis, rheumatoid arthritis, and osteonecrosis, which are diseases or injuries, and its purpose is to replace or restore a hip joint, thereby alleviating symptoms and restoring mobility. This aligns with the definition of a therapeutic device.
No
The device described is a hip implant (femoral stem) used for hip replacement surgery, which is a treatment, not a diagnostic procedure.
No
The device description clearly states it is a "Femoral Stem," which is a physical implant used in hip replacement surgery. The entire summary focuses on the physical characteristics and performance of this hardware component.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for hip replacement. This is a medical device used in vivo (within the body) for treatment.
- Device Description: The description details a femoral stem, which is a component of a hip implant.
- Anatomical Site: The device is used in the hip.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information. IVDs are used to diagnose diseases or conditions in vitro (outside the body).
This device is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.
. Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.
. Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
. Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.
Product codes (comma separated list FDA assigned to the subject device)
LZO, MEH, LWJ, and JDI
Device Description
The proposed Novation Splined RDD Press-Fit Femoral Stem is a modification of the predicate Novation 12/14 Splined Press-Fit Femoral Stems cleared through premarket notification #K042842. Both products share the same intended use and basic fundamental scientific technology and differ only in the proposed reduced distal crosssectional diameter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
skeletally mature individuals
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Engineering evaluations were conducted to verify that the performance of the proposed Novation Splined RDD Femoral Stems would be adequate for anticipated in pivo use. Based on successful results discussed in this submission, we conclude the proposed devices are substantially equivalent to Exactech's predicate femoral stems.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
K063279
NOV 29 2006
plined RDD Femoral Stems Exactecl
Special 510(k) - 510(k) Summary of Safety and Effectiveness
Exactech® Inc. Sponsor: 2320 N.W. 66th Court Gainesville, Florida 32653
Phone: | (352) - 377 - 1140 |
---|---|
Fax: | (352) - 378 - 2617 |
FDA Establishment Number 1038671
- Contact: Maritza Elias Regulatory Representative
Date: October 13, 2006
1
Exactech® Novation Splined RDD Femoral Stems
Special 510(k) - 510(k) Summary of Safety and Effectiveness
Trade or proprietary or model name(s):
Novation Splined RDD Femoral Stems
Information on devices to which substantial equivalence is claimed:
510(k) | Trade or Proprietary or Model Name | Manufacturer |
---|---|---|
Number | ||
#K042842 | Novation 12/14 Press-Fit Femoral Stems | Exactech, Inc. |
INDICATIONS FOR USE:
All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.
- . Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.
- . Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
- . Femoral heads and endoprostheses are intended for use in cemented and press-fit applications.
Device Description:
The proposed Novation Splined RDD Press-Fit Femoral Stem is a modification of the predicate Novation 12/14 Splined Press-Fit Femoral Stems cleared through premarket notification #K042842. Both products share the same intended use and basic fundamental scientific technology and differ only in the proposed reduced distal crosssectional diameter.
2
Exactech® Novation Splined RDD Femoral Stems
Special 510(k) - 510(k) Summary of Safety and Effectiveness
Substantial Equivalency Conclusion:
Engineering evaluations were conducted to verify that the performance of the proposed Novation Splined RDD Femoral Stems would be adequate for anticipated in pivo use. Based on successful results discussed in this submission, we conclude the proposed devices are substantially equivalent to Exactech's predicate femoral stems.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. The eagle is black, and the text is also black. The logo is simple and recognizable.
Public Health Service
NOV 2 9 2006
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Exactech, Inc. c/o Ms. Maritza Elias Regulatory Representative 2320 N.W. 66th Court Gainesville, Florida 32653
Re: K063279
Trade/Device Name: Novation Splined Reduced Distal Diameter (RDD) Femoral Stems Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or non-porous uncemented prosthesis Regulatory Class: II Product Code: LZO, MEH, LWJ, and JDI Dated: October 13, 2006 Received: October 31, 2006
Dear Ms. Elias:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
4
Page 2 - Ms. Maritza Elias
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Barbara Becker
Mark N. Melkerson, M.S. Director Division of General, Restorative and Neurological Devices · Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
K063279
Exactech® Novation Splined RDD Femoral Stems
Special 510(k) - Indications for Use
510(k) Number (if known):
Novation Splined RDD Femoral Stems Device Name:
INDICATIONS FOR USE:
All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.
- Cemented femoral stems and cemented acetabular cups are intended for cemented . fixation only.
- Press-fit femoral stems and acetabular cups are intended for press-fit fixation. . Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.
- Femoral heads and endoprostheses are intended for use in cemented and press-fit . applications.
Prescription Use X (Part 21 CFR 801 Subpart D) and/or
Over-The-Counter Use (21 CFR 807 Subpart C)
Please do not write below this line - use another page if needed.
Concurrence of CDRH, Office of Device Evaluation (ODE)
Kaubara Buchins
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
Rev 10/13/06
510(k) Number K063279
Section 3 Page 1 of 1